Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(14):1050-1051; doi:10.1093/jnci/djh161
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Henson, D. E.
Right arrow Articles by Albores-Saavedra, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henson, D. E.
Right arrow Articles by Albores-Saavedra, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

EDITORIAL

Checking up on the Surveillance, Epidemiology, and End Results Program

Donald E. Henson, Jorge Albores-Saavedra

Affiliations of authors: Office of Cancer Prevention and Control, The George Washington University Cancer Institute, The George Washington University Medical Center, Washington, DC (DEH); Louisiana State University Health Sciences Center, Shreveport (JAS)

Correspondence to: Donald E. Henson, MD, Office of Cancer Prevention and Control, The George Washington University Cancer Institute, The George Washington University Medical Center, Washington, DC (e-mail: patdeh@gwumc.edu)

The first 10% of the full text of this article appears below.

The SEER1 Program (Surveillance, Epidemiology, and End Results) of the National Cancer Institute has played a leading role in guiding public policy, stimulating research, and reflecting progress in cancer control in the United States. Begun in 1973, SEER collects and publishes cancer incidence and mortality data on more than 10% of the U.S. population. Currently, the SEER database contains more than 3 million cases of in situ and invasive cancer. In addition to demographic data, SEER collects variables such as histologic tumor type, estrogen receptor status in cases of breast cancer, and extent of disease, which are important clinical parameters.

Population based, SEER reflects cancer as seen . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Ann. Onc., August 1, 2006; 17(8): 1255 - 1262.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. E. Lally, D. Zelterman, J. M. Colasanto, B. G. Haffty, F. C. Detterbeck, and L. D. Wilson
Postoperative Radiotherapy for Stage II or III Non-Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database
J. Clin. Oncol., July 1, 2006; 24(19): 2998 - 3006.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver
In Reply:
J. Clin. Oncol., April 20, 2006; 24(12): 1963 - 1964.
[Full Text] [PDF]

Home page
 Arch DermatolHome page
M. J. Eide and M. A. Weinstock
Association of UV Index, Latitude, and Melanoma Incidence in Nonwhite Populations--US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001
Arch Dermatol, April 1, 2005; 141(4): 477 - 481.
[Abstract] [Full Text] [PDF]